Table 5 Association between SNPs in OSMR and patient’s survival

 GG

63/8

16/55

46/16

6/8

 GA

70/3

25/48

49/17

20/46

 AA

19/1

4/16

11/3

18/44

 Dominant

0.31 (0.09–1.06)

0.06

1.56 (0.0.84–2.89)

0.16

1.14 (0.57–2.26)

0.71

1.05 (0.56–1.96)

0.88

 Recessive

0.77 (0.10–6.10)

0.80

0.49 (0.17–1.39)

0.18

1.10 (0.31–3.94)

0.88

1.54 (0.60–3.97)

0.37

 Overdominant

0.31 (0.08–1.20)

0.09

2.16 (1.17–3.98)

0.01

1.10 (0.57–2.13)

0.78

0.89 (0.49–1.63)

0.71

 GG

66/9

15/60

48/13

15/46

 GT

66/3

23/46

47/19

24/42

 TT

20/0

7/13

11/4

5/10

 Dominant

0.22 (0.06–0.86)

0.029

1.74 (0.92–3.27)

0.08

1.36 (0.69–2.70)

0.38

1.45 (0.78–2.72)

0.24

 Recessive

NA (0–NA)

0.98

1.18 (0.51–2.71)

0.70

1.21 (0.43–3.52)

0.72

1.12 (0.36–2.88)

0.82

 Overdominant

0.37 (0.09–1.43)

0.15

1.58 (0.86–2.90)

0.14

1.25 (0.65–2.43)

0.50

1.37 (0.75–2.52)

0.30